Literature DB >> 8828614

Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency.

J Pietz1, U K Meyding-Lamadé, H Schmidt.   

Abstract

White matter abnormalities on MRI have been observed in phenylketonuria (PKU) patients with late onset neurological symptoms as well as in neurologically inconspicious patients. We investigated 14 early treated adolescents at an age between 12 and 17 years (mean age 14.3 years) with classical PKU as well as one retarded patient with atypical PKU by cranial MRI with spinecho T1-, T2- and proton density sequences. Clinical examination was normal. Visual evoked potential (VEP) examination showed a prolonged latency of peak P100 (mean 122.6 ms; control mean 115.9) and IQ testing showed a mean IQ of 101.1. To investigate the influence of plasma phenylalanine (Phe) levels three approaches were used: Phe was determined for the day of MRI, for a period of 6 months prior to MRI and for lifetime up to 12 years. MRI scans revealed areas of abnormally increased signal intensity on T2-weighted and proton density images in 12 (86%) patients, preferably involving the parieto-occipital lobes. MRI of the patient with atypical PKU was normal. MRI findings correlated most strongly to long-term dietary control up to 12 years. We found no correlation with the other parameters of biochemical control, IQ or VEP latency. The nature and prognosis of MRI abnormalities in neurologically normal PKU patients remain unclear although abnormalities in VEPs which were not associated with the degree of MRI abnormalities in our sample indicate a disturbance in myelination along the visual pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8828614     DOI: 10.1007/pl00014255

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

1.  The influence of phenylalanine intake on the chemistry and behaviour of a phenyl-ketonuric child.

Authors:  H BICKEL; J GERRARD; E M HICKMANS
Journal:  Acta Paediatr       Date:  1954-01       Impact factor: 2.299

2.  Neurological outcome in 22 treated adolescents with hyperphenylalaninemia. A clinical and electrophysiological study.

Authors:  A C Ludolph; K Ullrich; S Nedjat; H Masur; U Bick
Journal:  Acta Neurol Scand       Date:  1992-04       Impact factor: 3.209

3.  Central nervous system lesions in disorders of amino-acid metabolism. A neuropathological study.

Authors:  J J Martin; W Schlote
Journal:  J Neurol Sci       Date:  1972       Impact factor: 3.181

4.  Neurological deterioration in adult phenylketonuria.

Authors:  D Villasana; I J Butler; J C Williams; S M Roongta
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Localized brain proton NMR spectroscopy in young adult phenylketonuria patients.

Authors:  K Johannik; P Van Hecke; B François; G Marchal; M H Smet; J Jaeken; L Breysem; G Wilms; A L Baert
Journal:  Magn Reson Med       Date:  1994-01       Impact factor: 4.668

6.  In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy.

Authors:  E J Novotny; M J Avison; N Herschkowitz; O A Petroff; J W Prichard; M R Seashore; D L Rothman
Journal:  Pediatr Res       Date:  1995-02       Impact factor: 3.756

7.  Cranial CT and MRI in malignant phenylketonuria.

Authors:  F Gudinchet; P Maeder; R A Meuli; T Deonna; J M Mathieu
Journal:  Pediatr Radiol       Date:  1992

8.  Neurological deterioration in young adults with phenylketonuria.

Authors:  A J Thompson; I Smith; D Brenton; B D Youl; G Rylance; D C Davidson; B Kendall; A J Lees
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

9.  Biochemical control, genetic analysis and magnetic resonance imaging in patients with phenylketonuria.

Authors:  J H Walter; L A Tyfield; J B Holton; C Johnson
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

10.  Identification and quantitation of phenylalanine in the brain of patients with phenylketonuria by means of localized in vivo 1H magnetic-resonance spectroscopy.

Authors:  R Kreis; J Pietz; J Penzien; N Herschkowitz; C Boesch
Journal:  J Magn Reson B       Date:  1995-06
View more
  2 in total

1.  Diffusion tensor images in children with early-treated, chronic, malignant phenylketonuric: correlation with intelligence assessment.

Authors:  Steven Shinn-Forng Peng; Wen-Yih Isaac Tseng; Yin-Hsiu Chien; Wuh-Liang Hwu; Hon-Man Liu
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

2.  Cranial MR spectroscopy of tetrahydrobiopterin deficiency.

Authors:  Yin-Hsiu Chien; Shiin-Feng Peng; Tso-Ren Wang; Wuh-Liang Hwu
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.